Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -46.86%. However, over the last six months, the performance has been stronger by -57.31%. The price of SXTC decreased -19.14% over the last 30 days. And in the last five days, it has fallen by -18.80%.
China SXT Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $11.92 on 07/12/24, while the lowest price for the same period was registered at $0.97 on 04/16/25.
52-week price history of SXTC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. China SXT Pharmaceuticals Inc’s current trading price is -81.88% away from its 52-week high, while its distance from the 52-week low is 122.68%. The stock’s price range during this period has varied between$0.97 and $11.92. The China SXT Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 51.58 million for the day, a figure considerably higher than their average daily volume of 0.14 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
China SXT Pharmaceuticals Inc (SXTC) has experienced a quarterly decline of -34.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.73M and boasts a workforce of 75 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.23, with a change in price of -0.91. Similarly, China SXT Pharmaceuticals Inc recorded 677,169 in trading volume during the last 100 days, posting a change of -29.56%.
SXTC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SXTC stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.02.
SXTC Stock Stochastic Average
As of today, China SXT Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 17.32%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 56.13%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 19.71% and 14.45%, respectively.
